 |
Prenetics
Last updated: April 19, 2024
Danny Yeung, CEO
Country: Hong Kong | Funding: $187.7M (+)
Website: http://www.prenetics.com/
We are a rapidly growing DNA Biotechnology company specializing in Pharmacogenomics. Our proprietary technology enables physicians to help patients identify the right drug, right dosage and to list out potential adverse drug effects (ADE’s), based on one’s genetic profile. Our vision is to improve quality of life, prevent ADE’s and to save on healthcare costs by providing the tools essential for personalized medication management.
Website: http://www.prenetics.com/
We are a rapidly growing DNA Biotechnology company specializing in Pharmacogenomics. Our proprietary technology enables physicians to help patients identify the right drug, right dosage and to list out potential adverse drug effects (ADE’s), based on one’s genetic profile. Our vision is to improve quality of life, prevent ADE’s and to save on healthcare costs by providing the tools essential for personalized medication management.
